您当前所在位置:首页 > 资讯信息 > 新品上市
利用DSPE-PEG-NHS偶联抗叶酸代谢物构建靶向纳米脂质体的应用研究
发布时间:2025-06-24     作者:zyl   分享到:

文献:Synthesis and evaluations of three folate analogue-lipid conjugates as the targeting materials for treatment of invasive breast cancer

文献链接:https://xueshu.baidu.com/usercenter/paper/show?paperid=124c0t30bt340ps01e5106r0c8030546&site=xueshu_se

作者:Rui-Jun,Ju,Wan-Liang,Lu

摘要:

Objective:Specific binding between ligand and receptor is used as a targeting strategy to enhance the accumulation of drug-loaded liposomes in the cancer tissues.Folate receptor has been found to be overexpressed on invasive breast cancer cells.In the present study,three kinds of folate analogue-lipid conjugates were synthetized and evaluated as the targeting ligands of folate receptor for modifying drug-toaded liposomes to improve the efficacy in treatment of invasive breast cancer.Methods:Three folate analogues,aminopterin,pemetrexed and raltitrexed,were selected as the targeting molecules and were conjugated with N-hydroxysuccinimidyl-polyethylene glycol distearoylphosphatidyl ethanolamine(DSPE-PEG2000-NHS).The synthesized conjugates were confirmed by a matrix-assisted laser desorption/ionization time of flight mass spectrometry(MALDI-TOF-MS).Nanostructured targeting liposomes were subsequently developed by incorporating these targeting conjugates onto the surface of liposomes,respectively.

Gso6k8KkkM7RycDaQNRv.png

目的:

利用配体与受体的特异性结合作为靶向策略,促进药物脂质体在*症组织中的积累。叶酸受体已被发现在侵袭性乳腺*症细胞上过表达。本研究合成了三种叶酸类似物-脂质偶联物,并将其作为叶酸受体的靶向配体,用于修饰药物脂质体,以提高侵袭性乳腺*症的治疗效果。

方法:选择三种叶酸类似物,氨基蝶呤、培美曲塞和拉替曲塞作为靶向分子,并与N-羟基琥珀酰亚胺基-聚乙二醇二硬脂酰-磷脂酰乙醇胺(DSPE-PEG2000-NHS)偶联。通过基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF-MS)证实了合成的偶联物。

随后,通过将这些靶向偶联物分别掺入脂质体表面,开发了纳米结构靶向脂质体。

相关推荐产品:

DSPE-PEG-NBD

DSPE-PEG-TRITC

DSPE-PEG-Comarin

DSPE-PEG-ICG

DSPE-PEG-Pyrene

DSPE-PEG-Ce6

版权声明:

本平台根据相关科技期刊文献、教材以及网站编译整理的内容,仅用于对相关科学作品的介绍、评论以及课堂教学或科学研究。如有侵权,请联系我们删除。


库存查询